Saturday, December 27, 2014

Trice Med raises $12M for needle camera

Safeguard, Biostar Ventures in deal

Trice Med raises $12M for needle camera

Safeguard Scientifics, Wayne, has joined Michigan-based Biostar Ventures and other investors pumping $11.6 million into Trice Medical, a King of Prussia company that makes "mi-eye," a mini-camera and light mounted on a 14-gauge needle -- the kind they use in vaccinations -- and wired to an Android tablet, which CEO Jeff O'Donnell tells me can be used to probe hips and shoulders, "averting the need for an expensive MRI" or exploratory surgery. 

O'Donnell is a serial startup CEO: He previously ran Embrella Cardiovascular of Wayne, which he sold to Edwards Life Sciences in March 2011 for $43 million, four times what investors put in. He also ran Photomedex (based in Montgomeryville), Kensey Nash of Exton, and Cardiovascular Dynamics, Irvine, Calif.

Joseph N. DiStefano
About this blog

PhillyDeals posts raw drafts and updates of Joseph N. DiStefano's columns and stories about Philly-area finance, investment, commercial real estate, tech, hiring and public spending, which he's been writing since 1989, mostly for the Philadelphia Inquirer.

DiStefano studied economics, history and a little engineering at Penn, taught writing at St. Joe's, and has written the book Comcasted, more than a thousand columns, and thousands of articles, and raised six children with his wife, who is a saint.

Reach Joseph N. at JoeD@phillynews.com or 215 854 5194.

Joseph N. DiStefano
Business Videos:
Also on Philly.com:
Stay Connected